We have received text from S. 2398: Kay Hagan Tick Reauthorization Act. This bill was received on 2025-07-23, and currently has 10 cosponsors.
Here is a short summary of the bill:
The proposed legislation, known as the Kay Hagan Tick Reauthorization Act, aims to continue and expand federal efforts to address tick-borne diseases in the United States. Here is a summary of its main features:
Short Title
The bill will be formally referred to as the "Kay Hagan Tick Reauthorization Act."
Reauthorization of Programs
The bill seeks to reauthorize certain programs that focus on combating vector-borne diseases, particularly those spread by ticks. This includes:
National Strategy and Regional Centers of Excellence in Vector-Borne Disease
Under this section, the bill modifies existing legislation concerning the national strategy and the establishment of regional centers of excellence that specialize in addressing vector-borne diseases. Key changes include:
- The removal of a specific reference to the "Tick-Borne Disease Working Group" which was established earlier under the 21st Century Cures Act. Instead, the bill proposes a more general inclusion of "appropriate individuals" for consultation.
- The reauthorization period for certain initiatives will be extended from 2021-2025 to 2026-2030, allowing ongoing focus and resources directed towards ticks and associated diseases.
Enhanced Support for Health Departments
The bill also aims to provide improved assistance to health departments, helping them tackle vector-borne diseases more effectively. Similar to the first subsection, it extends the support period from 2021-2025 to 2026-2030.
Impact on Health and Research
By reauthorizing and modifying these programs, the legislation seeks to bolster federal resources and strategic efforts to address the growing concern of tick-borne diseases, which have been on the rise in recent years. It aims to enhance disease prevention, research, and response efforts at both the national and regional levels.
Relevant Companies
None found.
Senator Susan M. Collins Bill Proposals
Here are some bills which have recently been proposed by Senator Susan M. Collins:
- S.2399: A bill to establish a payment program for unexpected loss of markets and revenues to timber harvesting and timber hauling businesses due to major disasters, and for other purposes.
- S.2398: A bill to reauthorize the Kay Hagan Tick Act, and for other purposes.
- S.2294: A bill to reauthorize the Kay Hagan Tick Act, and for other purposes.
- S.2211: Special Diabetes Program Reauthorization Act of 2025
- S.2012: Runaway and Homeless Youth and Trafficking Prevention Act of 2025
- S.1805: Promoting Access to Diabetic Shoes Act
You can track bills proposed by Senator Susan M. Collins on Quiver Quantitative's politician page for Collins.
Senator Susan M. Collins Net Worth
Quiver Quantitative estimates that Senator Susan M. Collins is worth $6.2M, as of July 29th, 2025. This is the 130th highest net worth in Congress, per our live estimates.
Collins has approximately $3.7M invested in publicly traded assets which Quiver is able to track live.
You can track Senator Susan M. Collins's net worth on Quiver Quantitative's politician page for Collins.
Senator Susan M. Collins Stock Trading
We have data on up to $115.8M of trades from Senator Susan M. Collins, which we parsed from STOCK Act filings. Some of the largest trades include:
- A February 20th, 2015 purchase of up to $50M of $MMM. The stock has risen 8.17% since then.
- A December 16th, 2020 sale of up to $100K of $DNKN.
- A May 17th, 2019 sale of up to $100K of $RHT. The stock has risen 1.19% since then.
- A June 18th, 2018 purchase of up to $50K of $STZ. The stock has fallen 25.69% since then.
- A January 21st, 2022 sale of up to $50K of $UL. The stock has risen 20.08% since then.
You can track Senator Susan M. Collins's stock trading on Quiver Quantitative's politician page for Collins.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
